PIGHI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 722
EU - Europa 578
AS - Asia 387
AF - Africa 31
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.723
Nazione #
US - Stati Uniti d'America 717
SG - Singapore 204
CN - Cina 152
RU - Federazione Russa 119
IT - Italia 108
IE - Irlanda 83
FR - Francia 77
SE - Svezia 57
DE - Germania 54
FI - Finlandia 31
TG - Togo 30
GB - Regno Unito 14
KR - Corea 12
BE - Belgio 8
NL - Olanda 7
HK - Hong Kong 5
VN - Vietnam 5
AT - Austria 4
AU - Australia 4
CA - Canada 4
ES - Italia 4
LT - Lituania 4
IR - Iran 3
ID - Indonesia 2
PL - Polonia 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CZ - Repubblica Ceca 1
EG - Egitto 1
EU - Europa 1
IS - Islanda 1
PA - Panama 1
PH - Filippine 1
RO - Romania 1
TR - Turchia 1
UA - Ucraina 1
Totale 1.723
Città #
Chandler 244
Singapore 171
Ashburn 104
Dublin 80
Beijing 38
Lomé 30
Helsinki 22
Lawrence 22
Princeton 22
Seattle 22
Verona 22
Redmond 20
Sindelfingen 18
Wilmington 16
Munich 12
Seoul 12
Milan 11
Moscow 11
Brussels 8
Lappeenranta 8
Amsterdam 7
Ann Arbor 7
Shenzhen 7
Guangzhou 6
Pescantina 6
Ancona 5
Bonndorf 5
Hong Kong 5
New York 5
Rome 5
Santa Clara 5
Southend 5
Tianjin 5
Dallas 4
Frankfurt am Main 4
London 4
Peschiera del Garda 4
Tappahannock 4
Vienna 4
Washington 4
Woodbridge 4
Xi'an 4
Zhengzhou 4
Dongguan 3
Fairfield 3
Levallois-perret 3
Los Angeles 3
Madrid 3
Neumünster 3
Norwalk 3
Paris 3
Taizhou 3
Treviso 3
Bratislava 2
Cambridge 2
Changsha 2
Chiuppano 2
Dong Ket 2
Durham 2
Fuzhou 2
Krakow 2
Ottawa 2
San Francisco 2
San Giovanni Lupatoto 2
Shanghai 2
Trevenzuolo 2
Turin 2
Bentivoglio 1
Boardman 1
Bologna 1
Brescia 1
Brisbane 1
Bucharest 1
Buffalo 1
Cairo 1
Canberra 1
Cassano delle Murge 1
Catania 1
Chicago 1
Chongqing 1
Clonee 1
Dhaka 1
Dubai 1
Edinburgh 1
Fremont 1
Gunzenhausen 1
Haikou 1
Hangzhou 1
Hebei 1
Ho Chi Minh City 1
Jakarta 1
Johnstown 1
Laurel 1
Lviv 1
Manila 1
Marino 1
Mataró 1
Melbourne 1
Miami 1
Montignoso 1
Totale 1.097
Nome #
Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers 74
Clinical assessment of FREND COVID-19 Ag test in an unselected population referred for routine SARS-CoV-2 testing 74
Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit 66
Anti-spike S1 IgA, anti-spike trimeric IgG, and anti-spike RBD IgG response after BNT162b2 COVID-19 mRNA vaccination in healthcare workers 65
The pronounced decline of anti-SARS-CoV-2 spike trimeric IgG and RBD IgG in baseline seronegative individuals six months after BNT162b2 vaccination is consistent with the need for vaccine boosters 62
Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination 61
Comparison of five commercial anti-SARS-CoV-2 total antibodies and IgG immunoassays after vaccination with BNT162b2 mRNA 61
Performance of Fujirebio Espline SARS-CoV-2 rapid antigen test for identifying potentially infectious individuals 61
Clinical Assessment of the DiaSorin LIAISON SARS-CoV-2 Ag Chemiluminescence Immunoassay 58
Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series 55
Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassay 53
Variation of Forehead Temperature during Routine Working Shift in Hospital Laboratory Personnel: Implications for SARS-CoV-2 Screening 51
Evaluation of indoor hospital acclimatization of body temperature before COVID-19 fever screening 48
Three-month ad interim analysis of total anti-SARS-CoV-2 antibodies in healthy recipient of a single BNT162b2 vaccine booster 48
Effect of BNT162b2 booster dose on anti-SARS-CoV-2 spike trimeric IgG antibodies in seronegative individuals 47
Comparative longitudinal variation of total IgG and IgA anti-SARS-CoV-2 antibodies in recipients of BNT162b2 vaccination 46
Clinical performance of the Roche Elecsys SARS-CoV-2 antigen fully automated electrochemiluminescence immunoassay 42
SARS-CoV-2 Omicron infection is associated with high nasopharyngeal viral load 38
Longitudinal monitoring of anti-SARS-CoV-2 RBD IgG antibodies after BNT162b2 vaccination in healthcare workers 38
Serum C reactive protein predicts humoral response after BNT162b2 booster administration 36
Humoral response post-BNT162b2 single booster in pre-vaccination baseline SARS-CoV-2 seronegative and seropositive subjects 33
Association between viral load and positivization time of a SARS-CoV-2 rapid antigen test in routine nasopharyngeal specimens 32
Effect of syringe underfilling on the quality of venous blood gas analysis 32
Monoclonal gammopathy in SARS-CoV-2 infection 31
Positivization time of a COVID-19 rapid antigen self-test predicts SARS-CoV-2 viral load: a proof of concept 31
Assessment of humoral and cellular immunity after bivalent BNT162b2 vaccination and potential association with reactogenicity 29
Clinical performance of Fujirebio Lumipulse G SARSCoV- 2 Ag chemiluminescent immunoassay 29
Analytical evaluation of the novel Mindray high sensitivity cardiac troponin I immunoassay on CL-1200i 28
Are anti-SARS-CoV-2 S/N IgG/IgM antibodies always predictive of previous SARS-CoV-2 infection? 27
Impact of BNT162b2 primary vaccination and homologous booster on anti-SARS-CoV-2 IgA antibodies in baseline seronegative healthcare workers 27
Clinical assessment of SNIBE Maglumi SARS-CoV-2 antigen fully-automated chemiluminescent immunoassay 26
Cellular immunity against SARS-CoV-2 depends on the serological status 25
Real-world assessment of the clinical performance of COVID-VIRO ALL IN rapid SARS-CoV-2 antigen test 22
Correlation Between Time to Positive Result of SARS-CoV-2 Rapid Antigen Self-Test and Viral Antigen Concentration 22
Monitoring humoral and cellular immunity over 6 months after mRNA-based bivalent COVID-19 vaccine administration 21
Total anti-SARS-CoV-2 antibodies measured 6 months after Pfizer-BioNTech COVID-19 vaccination in healthcare workers 21
Cost-effectiveness analysis of different COVID-19 screening strategies based on rapid or laboratory-based SARS-CoV-2 antigen testing 20
Variation of Total Anti-SARS-CoV-2 Antibodies After Primary BNT162b2 Vaccination and Homologous Booster 19
Reliability of a single-nostril nasopharyngeal swab for diagnosing SARS-CoV-2 infection 19
Accuracy of screening for hemolysis in plasma samples using a commercial urine dipstick 19
Impact of an air bubble within the syringe on test results obtained with a modern blood gas analyzer 18
Impact of the COVID-19 pandemic on the volume of laboratory testing 18
Can cellular and humoral immunity predict response to BNT162b2 bivalent booster? 18
Early kinetics of cellular immunity in recipients of bivalent BNT162b2 vaccine: a proof-of-concept study 17
Clinical assessment of Ortho VITROS SARS-CoV-2 antigen chemiluminescence immunoassay 16
Serum levels of prostate specific antigen (PSA) after primary vaccination with BNT162b2 16
Effect of exogenous lipids contamination on blood gas analysis 16
Generative artificial intelligence (AI) for reporting the performance of laboratory biomarkers: not ready for prime time 15
Preanalytical Impact of Incomplete K2EDTA Blood Tube Filling in Molecular Biology Testing 15
The incremental impact of comorbidities in COVID-19-related deaths compared to patients dying from cancer or cardiovascular disease 14
Update on Patient Self-Testing with Portable and Wearable Devices: Advantages and Limitations 14
Humoral response is enhanced after ipsilateral double intramuscular injection of BNT162b2 COVID-19 vaccine 13
Vaccination time does not influence total anti-SARS-CoV-2 antibodies response 12
Is mixing of blood gas syringes after collection really necessary? 10
Urine dipstick for screening plasma glucose and bilirubin in low resource settings: a proof-of-concept study 6
Totale 1.815
Categoria #
all - tutte 10.850
article - articoli 10.684
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 166
Totale 21.700


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202124 0 0 0 0 0 0 0 0 2 3 2 17
2021/2022205 29 37 7 8 10 4 4 6 14 8 26 52
2022/2023621 36 51 58 116 31 126 23 54 63 9 29 25
2023/2024433 19 30 29 45 66 48 43 71 4 25 38 15
2024/2025532 65 84 90 185 61 47 0 0 0 0 0 0
Totale 1.815